Toxic metabolic syndrome associated with HAART. - Wikidata - wikimedia - TriplyDB

Toxic metabolic syndrome associated with HAART.

Toxic metabolic syndrome associated with HAART.

http://www.wikidata.org/entity/Q36544924

about

Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006.COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection.Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD).Antiretroviral-related adipocyte dysfunction and lipodystrophy in HIV-infected patients: Alteration of the PPARγ-dependent pathways A review of nucleoside reverse transcriptase inhibitor use to prevent perinatal transmission of HIV.Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir.

P2860

Q31143771-C2A924EC-8C27-4844-B691-911CE5F22D02 Q33640397-621454D1-00BF-4E3C-B66D-01F74D117367 Q33996797-F015F7F6-3B53-4816-8C30-9E4BB17BD935 Q34588220-3C27DA87-8EE5-4398-99EF-7D706DDE8A35 Q35076628-5D62C033-B2BD-4856-8F02-2130E33C547C Q35898696-91BC78C2-89D6-4235-AB27-AA3E368EFD0F Q37033675-C636DA0E-F165-475C-A249-0B7FB073B297 Q37588728-535CD9FE-D596-4D01-999D-5DF0D6ECDEF1 Q39195226-F2523B8C-B2B1-49FC-8A85-1EE0250088B4 Q42176233-CC8C54BA-7B28-4505-B2AD-87DDC4CBF585

P2860

Toxic metabolic syndrome associated with HAART.

http://www.wikidata.org/entity/Q36544924

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Toxic metabolic syndrome associated with HAART.

@ast

Toxic metabolic syndrome associated with HAART.

@en

type

label

Toxic metabolic syndrome associated with HAART.

@ast

Toxic metabolic syndrome associated with HAART.

@en

prefLabel

Toxic metabolic syndrome associated with HAART.

@ast

Toxic metabolic syndrome associated with HAART.

@en

P1433

Q36544924-EF0581A7-10C6-46D9-A8DC-6938B561DD4E

P1476

Q36544924-0D4E9CA1-0F03-4736-9DE5-C0A1C8FE1861

P2093

Q36544924-185F90F4-1BB8-46B0-B646-1F47C5E5EB6E

P2860

Q36544924-00930EEF-C26E-483E-98F7-518038388605

Q36544924-030F3FD6-624C-4568-9DCA-11EE9C02F19B

Q36544924-05F1CACE-79CF-4074-8C05-88932A882D3C

Q36544924-08ED5426-6E7B-464A-87DA-0724AA45BA35

Q36544924-0BDEA94B-BC68-45F6-A6F2-F6B0874D9547

Q36544924-0C834116-7A0D-433B-A83D-0F5D2AD2659D

Q36544924-0CE32CCA-5ECC-425D-BED7-84DC8E463254

Q36544924-0D0B4C54-7127-4E04-8897-B36DED6FD9EB

Q36544924-0FE36142-5D7C-47E6-91DC-15054CCB68EA

Q36544924-107AFE25-A0CD-44C3-A2CA-6AF6EAD0C206

P304

Q36544924-24173B73-DCE4-49F3-9443-F00CDEE7CACD

P31

Q36544924-4D1C2EE8-EF76-4F8F-AFEE-B55129069F60

P356

Q36544924-AB5CB5A0-B298-4EB5-89B3-90E3D1C10BF9

P407

Q36544924-DB871C95-A207-483C-8BD1-201AAD277C13

P433

Q36544924-E814A276-BEAE-412E-AB6F-B6244B4D2D1D

P478

Q36544924-F26D1C48-A0C0-49CA-B6C7-3559B7F27CBD

P50

Q36544924-A6CC0663-32D8-4C71-BD15-9D495CA29DBC

P577

Q36544924-86C2CAA6-7E79-45B6-BECF-48ABCF0494B5

P698

Q36544924-7B4314F7-5C0D-43CD-B18B-CFE09933567A

P921

Q36544924-2FE05E96-2B2F-4BEB-9C99-8DD7DFC74F47

P356

17425255.2.3.429

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Toxic metabolic syndrome associated with HAART

@en

P2093

Steen B Haugaard

http://www.w3.org/2001/XMLSchema#string

P2860

Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade

Metabolic effects of indinavir in healthy HIV-seronegative men

Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.

Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy.

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

HDL metabolism in hypertriglyceridemic states: an overview.

Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells.

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

P304

429-445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2.3.429

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Steen Bendix Haugaard

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16863444

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome